It’s everything that makes Morningstar special: data and research, ratings, analytics, design, and a mission of empowering investor success.

Plus, two cheap utilities stocks as AI transforms the overlooked sector into a growth opportunity.

The Fed’s largest and fastest rate-hike cycle in 40 years—a 5.25% fed-funds rate increase between March 2022 and July 2023—was widely expected to generate a recession in 2023. Yet, real ...

The strength of the US economy continues to surprise. Even after the Federal Reserve raised interest rates at an ...

What are consumers spending money on? We expect Target’s more discretionary categories, such as home furnishings, ...

We expect gross domestic product growth to weaken over the next year before beginning to reaccelerate in the second half of 2025 on the back of Fed rate cuts. Growth will be weaker than normal ...

The Bureau of Labor Statistics reported that the Consumer Price Index climbed 3.4% in April from year-ago levels—a tick down ...

What is needed to get inflation to slow to low pre-pandemic levels, they say, is a U.S. economy returning to a more customary rate of growth. Somewhat less consumer demand would force business to ...

The marquee event is delivering the commencement address at Morehouse College, the prestigious, all-male historically Black college and the alma mater of Dr. Martin Luther King Jr. on Sunday. After ...

A victory by Donald Trump in this year's presidential election could result in sharply reduced spending on the energy transition and delay peak fossil fuel demand by about 10 years beyond current ...

European stocks traded lower on Friday, tracking declines in Asia and the U.S., as stocks reversed the rally that followed this week's U.S. inflation data. "A sea of red at the market close left U.S.

Johnson & Johnson-linked biopharmaceutical company Rapport Therapeutics on Friday filed for an initial public offering with the Securities and Exchange Commission.